Loading...
Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
Abnormal histone deacetylase (HDAC) expression is closely related to cancer development and progression. Many HDAC inhibitors have been widely used in cancer treatment; however, severe side effects often limit their clinical application. In this study, we attempted to identify natural compounds with...
Saved in:
| Published in: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052045/ https://ncbi.nlm.nih.gov/pubmed/32158695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|